Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 110 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1091 10.8 months Metastatic urothelial carcinoma 4 Chemotherapy
Odette Cancer Centre Canada 7/2013
Treatment Details: Patients: This phase 2 study involved 48 metastatic urothelial carcinoma patients who had been previously treated with platinum-based chemotherapy. The median patient age was 66 years and
 
1092 10.8 months Advanced Metastatic Melanoma 4 Chemotherapy
INSERM France 1/2015
Treatment Details: Patients: This phase 3 study involved 208 advanced metastatic melanoma patients. The median patient age was 66 years and 60.1% were male. Treatment: Patients received chemotherapy with
 
1093 10.8 months Metastatic Prostate Cancer 5 Biologic therapy
Massachusetts General Hospital United States 10/2014
Treatment Details: Patients: This phase 2 study involved 144 metastatic castration-resistant prostate cancer patients who had received prior chemotherapy. The median patient age was 65 years. Treatment:
 
1094 10.7 months Advanced Castration-Resistant Prostate Cancer 3 Chemotherapy
University of Siena Italy 3/2015
Treatment Details: Patients: This study involved 26 advanced, metastatic castration-resistant prostate cancer patients who had been previously treated with docetaxel and abiraterone acetate. The median patien
 
1095 10.7 months Squamous cell NSCLC 4 Chemotherapy
University of Pittsburgh Cancer Institute United States 9/2013
Treatment Details: Patients: This study involved squamous cell non-small-cell lung cancer patients who were divided into two separate treatment groups. Group A consisted of 229 patients with a median age of
 
1096 10.7 months Malignant mesothelioma 4 Biologic therapy
Azienda Ospedaliera Universitaria Senese Italy 10/2013
Treatment Details: Patients: This phase 2 study involved 29 advanced malignant mesothelioma patients who had received previous platinum-based chemotherapy. The median patient age was 64 years and 72% were ma
 
1097 10.7 months Diffuse large B-cell lymphoma 5 Biologic therapy
The University of Texas MD Anderson Cancer Center United States 9/2013
Treatment Details: Patients: This phase 2 study involved 45 patients with diffuse large B-cell lymphoma, transformed large cell lymphoma, or grade 3 follicular lymphoma. The median patient age was 66 years a
 
1098 10.7 months Advanced hepatocellular carcinoma 4 National Taiwan University Hospital Taiwan Region 7/2013
Treatment Details: Patients: This phase 2 study involved 51 advanced hepatocellular carcinoma patients who had no prior treatment. The median patient age was 58 years and 86% were male. Treatment: Patien
 
1099 10.7 months NSCLC 5 Chemotherapy
University Medical Center Mannheim Germany 4/2011
Treatment Details: Patients: This study involved non-small cell lung cancer patients that had not received prior chemotherapy. Patients were divided into 2 separate treatment groups. Group A consisted of 41
 
1100 10.7 months GBM Biologic therapy
Radiation
Surgery
M.D. Anderson Cancer Center United States 7/2006
Treatment Details: Patients: This study involved 162 patients with intracranial glioblastoma multiforme or gliosarcomas. They were from 20 different cancer treatment centers. Fifty-four of the patients were
 
Page 110 of 187  | Previous Page  | Next Page